Salarius Pharmaceuticals
SLRX
SLRX
52 hedge funds and large institutions have $98.6M invested in Salarius Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 8 closing their positions.
Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
20
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $1K | 71 | -1,013 | -93% |
|
52
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $12 | 722 | +722 | New |
|
|
SFM
53
Soros Fund Management
New York
| – | – | -30,000 | Closed |
|
54
D.E. Shaw & Co
New York
| – | – | -29,901 | Closed |
|
|
SIM
55
Spark Investment Management
New York
| – | – | -22,000 | Closed |
|
|
CS
56
Credit Suisse
Zurich,
Switzerland
| – | – | -17,826 | Closed |
|
57
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -13,617 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | – | -1,556 | Closed |
|
59
UBS Group
Zurich,
Switzerland
| – | – | -1,233 | Closed |
|
|
CPA
60
Cowen Prime Advisors
New York
| – | – | -1,000 | Closed |
|